Armata Pharmaceuticals, Inc. revenue breakdown overview

Armata Pharmaceuticals, Inc. revenue for the last year amounted to 5.17 M USD, the most of which — 5.17 M USD — came from its highest performing source at the moment, Pathogen-specific Bacteriophage Therapeutics, the year earlier bringing 4.53 M USD. The greatest contribution to the revenue figure was made by United States and Australia — last year it brought Armata Pharmaceuticals, Inc. 5.17 M USD, and the year before that — 4.53 M USD.